相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Galectin-3 inhibitors: a patent review (2008-present)
Helen Blanchard et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2014)
Galectin-3 induces cell migration via a calcium-sensitive MAPK/ERK1/2 pathway
Xiaoge Gao et al.
ONCOTARGET (2014)
Increased Circulation of Galectin-3 in Cancer Induces Secretion of Metastasis-Promoting Cytokines from Blood Vascular Endothelium
Chen Chen et al.
CLINICAL CANCER RESEARCH (2013)
Galectin-3 Contributes to Melanoma Growth and Metastasis via Regulation of NFAT1 and Autotaxin
Russell R. Braeuer et al.
CANCER RESEARCH (2012)
Dietary Glycemic Load and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings From CALGB 89803
Jeffrey A. Meyerhardt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Galectin-3-A jack-of-all-trades in cancer
Anna U. Newlaczyl et al.
CANCER LETTERS (2011)
Novel Interaction of MUC4 and Galectin: Potential Pathobiological Implications for Metastasis in Lethal Pancreatic Cancer
Shantibhusan Senapati et al.
CLINICAL CANCER RESEARCH (2011)
Serum Galectin-2,-4, and -8 Are Greatly Increased in Colon and Breast Cancer Patients and Promote Cancer Cell Adhesion to Blood Vascular Endothelium
Hannah Barrow et al.
CLINICAL CANCER RESEARCH (2011)
The role of galectins in colorectal cancer progression
Hannah Barrow et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response
Anna I. Markowska et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis
Qicheng Zhao et al.
MOLECULAR CANCER (2010)
Circulating galectin-3 in the bloodstream: An emerging promoter of cancer metastasis
Lu-Gang Yu
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2010)
Circulating Galectin-3 Promotes Metastasis by Modifying MUC1 Localization on Cancer Cell Surface
Qicheng Zhao et al.
CANCER RESEARCH (2009)
Lectin-epithelial interactions in the human colon
Jonathan M. Rhodes et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
The determination of the levels of circulating galectin-1 and-3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy
Sven Saussez et al.
ORAL ONCOLOGY (2008)
The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression
Lu-Gang Yu
GLYCOCONJUGATE JOURNAL (2007)
Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer
Jeffrey A. Meyerhardt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion
Lu-Gang Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Elevated Golgi pH in breast and colorectal cancer cells correlates with the expression of oncofetal carbohydrate T-antigen
Antti Rivinoja et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
High serum galectin-3 in advanced melanoma: preliminary results
P Vereecken et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2006)
Galectins as modulators of tumour progression
FT Liu et al.
NATURE REVIEWS CANCER (2005)
Differential mucin expression in colon carcinoma HT-29 clones with variable resistance to 5-fluorouracil and methotrexate
E Leteurtre et al.
BIOLOGY OF THE CELL (2004)
CD44 and its partners in metastasis
S Jothy
CLINICAL & EXPERIMENTAL METASTASIS (2003)
Cell surface-expressed Thomsen-Friedenreich antigen in colon cancer is predominantly carried on high molecular weight splice variants of CD44
R Singh et al.
GLYCOBIOLOGY (2001)
Increasing the intra-Golgi pH of cultured LS174T goblet-differentiated cells mimics the decreased mucin sulfation and increased Thomsen-Friedenreich antigen (Galβ1-3GalNacα-) expression seen in colon cancer
BJ Campbell et al.
GLYCOBIOLOGY (2001)
分享论文
